S100B and brain natriuretic peptide predict functional neurological outcome after intracerebral haemorrhage

References

• Anon. (2008). Abstracts of the Neurocritical Care Society 6th Annual Meeting. October 23–25, 2008. Miami, Florida, USA. Neurocrit Care 9 (Suppl.):S3–196.
   Google Scholar
• Abilleira S, Montaner J, Molina C, Monasterio J, Castillo J, Alvarez-Sabin J. (2003). Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage. J Neurosurg 99:65–70.
   PubMed Web of Science ®Google Scholar
• Abraha HD, Butterworth RJ, Bath PM, Wassif WS, Garthwaite J, Sherwood RA. (1997). Serum S-100 protein, relationship to clinical outcome in acute stroke. Ann Clin Biochem 34:366–70.
   PubMed Web of Science ®Google Scholar
• Akdemir G, Luer MS, Dujovny M, Misra M. (1997). Intraventricular atrial natriuretic peptide for acute intracranial hypertension. Neurol Res 19:515–20.
   PubMed Web of Science ®Google Scholar
• Allard L, Lescuyer P, Burgess J, Leung KY, Ward M, Walter N, Burkhard PR, Corthals G, Hochstrasser DF, Sanchez JC. (2004). ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke. Proteomics 4:2242–51.
   PubMed Web of Science ®Google Scholar
• Biberthaler P, Mussack T, Wiedemann E, Kanz KG, Mutschler W, Linsenmaier U, Pfeifer KJ, Gippner-Steppert C, Jochum M. (2002). Rapid identification of high-risk patients after minor head trauma (MHT) by assessment of S-100B: ascertainment of a cut-off level. Eur J Med Res 7:164–70.
   PubMed Web of Science ®Google Scholar
• Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, Mayberg M, Morgenstern L, Ogilvy CS, Vespa P, Zuccarello M. (2007). Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 38:2001–23.
   PubMed Web of Science ®Google Scholar
• Buttner T, Weyers S, Postert T, Sprengelmeyer R, Kuhn W. (1997). S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke 28:1961–5.
   PubMed Web of Science ®Google Scholar
• Delgado P, Alvarez Sabin J, Santamarina E, Molina CA, Quintana M, Rosell A, Montaner J. (2006). Plasma S100B level after acute spontaneous intracerebral hemorrhage. Stroke 37:2837–9.
   PubMed Web of Science ®Google Scholar
• Ekmektzoglou KA, Xanthos T, Papadimitriou L. (2007). Biochemical markers (NSE, S-100, IL-8) as predictors of neurological outcome in patients after cardiac arrest and return of spontaneous circulation. Resuscitation 75:219–28.
   PubMed Web of Science ®Google Scholar
• Elting JW, Sulter GA, Kaste M, Lees KR, Diener HC, Hommel M, Versavel M, Teelken AW, De Keyser J. (2002). AMPA antagonist ZK200775 in patients with acute ischemic stroke: possible glial cell toxicity detected by monitoring of S-100B serum levels. Stroke 33:2813–18.
   PubMed Web of Science ®Google Scholar
• Epstein M, Loutzenhiser R, Friedland E, Aceto RM, Camargo MJ, Atlas SA. (1987). Relationship of increased plasma atrial natriuretic factor and renal sodium handling during immersion-induced central hypervolemia in normal humans. J Clin Invest 79:738–45.
   PubMed Web of Science ®Google Scholar
• Fang HY, Ko WJ, Lin CY. (2005). Plasma interleukin 11 levels correlate with outcome of spontaneous intracerebral hemorrhage. Surg Neurol 64:511–17, discussion 517-18.
   PubMedGoogle Scholar
• Floras JS. (1990). Sympathoinhibitory effects of atrial natriuretic factor in normal humans. Circulation 81:1860–73.
   PubMed Web of Science ®Google Scholar
• Foerch C, Curdt I, Yan B, Dvorak F, Hermans M, Berkefeld J, Raabe A, Neumann-Haefelin T, Steinmetz H, Sitzer M. (2006). Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. J Neurol Neurosurg Psychiatry 77:181–4.
   PubMed Web of Science ®Google Scholar
• Foerch C, Wunderlich MT, Dvorak F, Humpich M, Kahles T, Goertler M, Alvarez-Sabin J, Wallesch CW, Molina CA, Steinmetz H, Sitzer M, Montaner J. (2007). Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke. Stroke 38:2491–5.
   PubMed Web of Science ®Google Scholar
• Fukui S, Katoh H, Tsuzuki N, Ishihara S, Otani N, Ooigawa H, Toyooka T, Ohnuki A, Miyazawa T, Nawashiro H, Shima K. (2004). Focal brain edema and natriuretic peptides in patients with subarachnoid hemorrhage. J Clin Neurosci 11:507–11.
   PubMed Web of Science ®Google Scholar
• Garibi J, Bilbao G, Pomposo I, Hostalot C. (2002). Prognostic factors in a series of 185 consecutive spontaneous supratentorial intracerebral haematomas. Br J Neurosurg 16:355–61.
   PubMed Web of Science ®Google Scholar
• Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC. (2001). The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 32:891–7.
   PubMed Web of Science ®Google Scholar
• Iida H, Iida M, Takenaka M, Oda A, Uchida M, Fujiwara H, Dohi S. (2001). The effects of alpha-human atrial natriuretic peptide and milrinone on pial vessels during blood-brain barrier disruption in rabbits. Anesth Analg 93:177–82.
   PubMed Web of Science ®Google Scholar
• James ML, Blessing R, Bennett E, Laskowitz DT. (2009). Apolipoprotein E modifies neurological outcome by affecting cerebral edema but not hematoma size after intracerebral hemorrhage in humans. J Stroke Cerebrovasc Dis 18:144–9.
   PubMed Web of Science ®Google Scholar
• James ML, Warner DS, Laskowitz DT. (2008). Preclinical models of intracerebral hemorrhage: a translational perspective. Neurocrit Care 9:139–52.
   PubMed Web of Science ®Google Scholar
• Jonsson H, Johnsson P, Birch-Iensen M, Alling C, Westaby S, Blomquist S. (2001). S100B as a predictor of size and outcome of stroke after cardiac surgery. Ann Thorac Surg 71:1433–7.
   PubMed Web of Science ®Google Scholar
• Juvela S. (1995). Risk factors for impaired outcome after spontaneous intracerebral hemorrhage. Arch Neurol 52:1193–200.
   PubMed Web of Science ®Google Scholar
• Kanner AA, Marchi N, Fazio V, Mayberg MR, Koltz MT, Siomin V, Stevens GH, Masaryk T, Aumayr B, Vogelbaum MA, Barnett GH, Janigro D. (2003). Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions. Cancer 97:2806–13.
   PubMed Web of Science ®Google Scholar
• Koenig MA, Puttgen HA, Prabhakaran V, Reich D, Stevens RD. (2007). B-type natriuretic peptide as a marker for heart failure in patients with acute stroke. Intensive Care Med 33:1587–93.
   PubMed Web of Science ®Google Scholar
• Kokocinska D, Wieczorek P, Partyka R, Jarzab J, Jalowiecki P, Sikora J. (2007). The diagnostic utility of S-100B protein and TPA in patients with ischemic stroke. Neuro Endocrinol Lett 28:693–8.
   PubMed Web of Science ®Google Scholar
• Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, Khoury J. (1996). The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27:1304–5.
   PubMed Web of Science ®Google Scholar
• Laragh JH. (1985). Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med 313:1330–40.
   PubMed Web of Science ®Google Scholar
• Laskowitz DT, Blessing R, Floyd J, White WD, Lynch JR. (2005). Panel of biomarkers predicts stroke. Ann N Y Acad Sci 1053:30.
   PubMed Web of Science ®Google Scholar
• Lynch JR, Blessing R, White WD, Grocott HP, Newman MF, Laskowitz DT. (2004). Novel diagnostic test for acute stroke. Stroke 35:57–63.
   PubMed Web of Science ®Google Scholar
• Lynch JR, Wang H, McGirt MJ, Floyd J, Friedman AH, Coon AL, Blessing R, Alexander MJ, Graffagnino C, Warner DS, Laskowitz DT. (2005). Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke 36:2024–6.
   PubMed Web of Science ®Google Scholar
• McGirt MJ, Blessing R, Nimjee SM, Friedman AH, Alexander MJ, Laskowitz DT, Lynch JR. (2004). Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery 54:1369–73; discussion 1373-4.
   PubMed Web of Science ®Google Scholar
• Mizukoshi G, Katsura K, Katayama Y. (2005). Urinary 8-hydroxy-2’-deoxyguanosine and serum S100beta in acute cardioembolic stroke patients. Neurol Res 27:644–6.
   PubMed Web of Science ®Google Scholar
• Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H and others. (1991). Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87:1402–12.
   PubMed Web of Science ®Google Scholar
• Mukoyama M, Nakao K, Saito Y, Ogawa Y, Hosoda K, Suga S, Shirakami G, Jougasaki M, Imura H. (1990). Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 323:757–8.
   PubMed Web of Science ®Google Scholar
• Nakagawa K, Yamaguchi T, Seida M, Yamada S, Imae S, Tanaka Y, Yamamoto K, Ohno K. (2005). Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke. Cerebrovasc Dis 19:157–64.
   PubMed Web of Science ®Google Scholar
• Nogami M, Shiga J, Takatsu A, Endo N, Ishiyama I. (2001). Immunohistochemistry of atrial natriuretic peptide in brain infarction. Histochem J 33:87–90.
   PubMedGoogle Scholar
• Pettigrew LC, Kasner SE, Gorman M, Atkinson RP, Funakoshi Y, Ishibashi H. (2006). Effect of arundic acid on serum S-100beta in ischemic stroke. J Neurol Sci 251:57–61.
   PubMed Web of Science ®Google Scholar
• Reynolds MA, Kirchick HJ, Dahlen JR, Anderberg JM, McPherson PH, Nakamura KK, Laskowitz DT, Valkirs GE, Buechler KF. (2003). Early biomarkers of stroke. Clin Chem 49:1733–9.
   PubMed Web of Science ®Google Scholar
• Sanchez-Pena P, Pereira AR, Sourour NA, Biondi A, Lejean L, Colonne C, Boch AL, Al Hawari M, Abdennour L, Puybasset L. (2008). S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage. Crit Care Med 36:2267–73.
   PubMed Web of Science ®Google Scholar
• Sodeck GH, Domanovits H, Sterz F, Schillinger M, Losert H, Havel C, Kliegel A, Vlcek M, Frossard M, Laggner AN. (2007). Can brain natriuretic peptide predict outcome after cardiac arrest? An observational study. Resuscitation 74:439–45.
   PubMed Web of Science ®Google Scholar
• Stranjalis G, Korfias S, Psachoulia C, Kouyialis A, Sakas DE, Mendelow AD. (2007). The prognostic value of serum S-100B protein in spontaneous subarachnoid haemorrhage. Acta Neurochir (Wien) 149:231–7; discussion 237-8.
   PubMed Web of Science ®Google Scholar
• Sviri GE, Feinsod M, Soustiel JF. (2000). Brain natriuretic peptide and cerebral vasospasm in subarachnoid hemorrhage. Clinical and TCD correlations. Stroke 31:118–22.
   PubMed Web of Science ®Google Scholar
• Sviri GE, Shik V, Raz B, Soustiel JF. (2003). Role of brain natriuretic peptide in cerebral vasospasm. Acta Neurochir (Wien) 145:851–60; discussion 860.
   PubMed Web of Science ®Google Scholar
• Sviri GE, Soustiel JF, Zaaroor M. (2006). Alteration in brain natriuretic peptide (BNP). plasma concentration following severe traumatic brain injury. Acta Neurochir (Wien) 148:529–33; discussion 533.
   PubMed Web of Science ®Google Scholar
• Valli N, Gobinet A, Bordenave L. (1999). Review of 10 years of the clinical use of brain natriuretic peptide in cardiology. J Lab Clin Med 134:437–44.
   PubMed Web of Science ®Google Scholar
• Weglewski A, Ryglewicz D, Mular A, Jurynczyk J. (2005). [Changes of protein S100B serum concentration during ischemic and hemorrhagic stroke in relation to the volume of stroke lesion]. Neurol Neurochir Pol 39:310–17.
   PubMedGoogle Scholar
• Yarlagadda S, Rajendran P, Miss JC, Banki NM, Kopelnik A, Wu A, H, Ko, N, Gelb AW, Lawton MT, Smith WS, Young WL, Zaroff JG. (2006). Cardiovascular predictors of in-patient mortality after subarachnoid hemorrhage. Neurocrit Care 5:102–7.
   PubMed Web of Science ®Google Scholar